Literature DB >> 15623556

Normal gating of CFTR requires ATP binding to both nucleotide-binding domains and hydrolysis at the second nucleotide-binding domain.

Allan L Berger1, Mutsuhiro Ikuma, Michael J Welsh.   

Abstract

ATP interacts with the two nucleotide-binding domains (NBDs) of CFTR to control gating. However, it is unclear whether gating involves ATP binding alone, or also involves hydrolysis at each NBD. We introduced phenylalanine residues into nonconserved positions of each NBD Walker A motif to sterically prevent ATP binding. These mutations blocked [alpha-(32)P]8-N(3)-ATP labeling of the mutated NBD and reduced channel opening rate without changing burst duration. Introducing cysteine residues at these positions and modifying with N-ethylmaleimide produced the same gating behavior. These results indicate that normal gating requires ATP binding to both NBDs, but ATP interaction with one NBD is sufficient to support some activity. We also studied mutations of the conserved Walker A lysine residues (K464A and K1250A) that prevent hydrolysis. By combining substitutions that block ATP binding with Walker A lysine mutations, we could differentiate the role of ATP binding vs. hydrolysis at each NBD. The K1250A mutation prolonged burst duration; however, blocking ATP binding prevented the long bursts. These data indicate that ATP binding to NBD2 allowed channel opening and that closing was delayed in the absence of hydrolysis. The corresponding NBD1 mutations showed relatively little effect of preventing ATP hydrolysis but a large inhibition of blocking ATP binding. These data suggest that ATP binding to NBD1 is required for normal activity but that hydrolysis has little effect. Our results suggest that both NBDs contribute to channel gating, NBD1 binds ATP but supports little hydrolysis, and ATP binding and hydrolysis at NBD2 are key for normal gating.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15623556      PMCID: PMC544308          DOI: 10.1073/pnas.0408575102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

1.  Phloxine B interacts with the cystic fibrosis transmembrane conductance regulator at multiple sites to modulate channel activity.

Authors:  Zhiwei Cai; David N Sheppard
Journal:  J Biol Chem       Date:  2002-03-19       Impact factor: 5.157

2.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

3.  Functional analysis of the C-terminal boundary of the second nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator and structural implications.

Authors:  Martina Gentzsch; Andrei Aleksandrov; Luba Aleksandrov; John R Riordan
Journal:  Biochem J       Date:  2002-09-01       Impact factor: 3.857

4.  Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator.

Authors:  Hal A Lewis; Sean G Buchanan; Stephen K Burley; Kris Conners; Mark Dickey; Michael Dorwart; Richard Fowler; Xia Gao; William B Guggino; Wayne A Hendrickson; John F Hunt; Margaret C Kearins; Don Lorimer; Peter C Maloney; Kai W Post; Kanagalaghatta R Rajashankar; Marc E Rutter; J Michael Sauder; Stephanie Shriver; Patrick H Thibodeau; Philip J Thomas; Marie Zhang; Xun Zhao; Spencer Emtage
Journal:  EMBO J       Date:  2003-12-18       Impact factor: 11.598

5.  A heteromeric complex of the two nucleotide binding domains of cystic fibrosis transmembrane conductance regulator (CFTR) mediates ATPase activity.

Authors:  Jackie F Kidd; Mohabir Ramjeesingh; Fiona Stratford; Ling-Jun Huan; Christine E Bear
Journal:  J Biol Chem       Date:  2004-07-28       Impact factor: 5.157

6.  Dimeric cystic fibrosis transmembrane conductance regulator exists in the plasma membrane.

Authors:  Mohabir Ramjeesingh; Jackie F Kidd; Ling Jun Huan; Yanchun Wang; Christine E Bear
Journal:  Biochem J       Date:  2003-09-15       Impact factor: 3.857

7.  An intrinsic adenylate kinase activity regulates gating of the ABC transporter CFTR.

Authors:  Christoph Randak; Michael J Welsh
Journal:  Cell       Date:  2003-12-26       Impact factor: 41.582

8.  Distinct Mg(2+)-dependent steps rate limit opening and closing of a single CFTR Cl(-) channel.

Authors:  Athanasios G Dousmanis; Angus C Nairn; David C Gadsby
Journal:  J Gen Physiol       Date:  2002-06       Impact factor: 4.086

9.  Prolonged nonhydrolytic interaction of nucleotide with CFTR's NH2-terminal nucleotide binding domain and its role in channel gating.

Authors:  Claudia Basso; Paola Vergani; Angus C Nairn; David C Gadsby
Journal:  J Gen Physiol       Date:  2003-09       Impact factor: 4.086

10.  On the mechanism of MgATP-dependent gating of CFTR Cl- channels.

Authors:  Paola Vergani; Angus C Nairn; David C Gadsby
Journal:  J Gen Physiol       Date:  2003-01       Impact factor: 4.086

View more
  45 in total

1.  The H-loop in the second nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator is required for efficient chloride channel closing.

Authors:  Monika Kloch; Michał Milewski; Ewa Nurowska; Beata Dworakowska; Garry R Cutting; Krzysztof Dołowy
Journal:  Cell Physiol Biochem       Date:  2010-01-12

Review 2.  Update in cystic fibrosis 2005.

Authors:  Frank J Accurso
Journal:  Am J Respir Crit Care Med       Date:  2006-05-01       Impact factor: 21.405

Review 3.  The ABC protein turned chloride channel whose failure causes cystic fibrosis.

Authors:  David C Gadsby; Paola Vergani; László Csanády
Journal:  Nature       Date:  2006-03-23       Impact factor: 49.962

4.  The deviant ATP-binding site of the multidrug efflux pump Pdr5 plays an active role in the transport cycle.

Authors:  Christopher Furman; Jitender Mehla; Neeti Ananthaswamy; Nidhi Arya; Bridget Kulesh; Ildiko Kovach; Suresh V Ambudkar; John Golin
Journal:  J Biol Chem       Date:  2013-09-09       Impact factor: 5.157

5.  Theoretical study of a membrane channel gated by ATP.

Authors:  J G Orlandi; J M Sancho
Journal:  Eur Phys J E Soft Matter       Date:  2009-07-04       Impact factor: 1.890

6.  A mutation in CFTR modifies the effects of the adenylate kinase inhibitor Ap5A on channel gating.

Authors:  Qian Dong; Christoph O Randak; Michael J Welsh
Journal:  Biophys J       Date:  2008-09-19       Impact factor: 4.033

7.  Observing a model ion channel gating action in model cell membranes in real time in situ: membrane potential change induced alamethicin orientation change.

Authors:  Shuji Ye; Hongchun Li; Feng Wei; Joshua Jasensky; Andrew P Boughton; Pei Yang; Zhan Chen
Journal:  J Am Chem Soc       Date:  2012-04-03       Impact factor: 15.419

8.  Converting nonhydrolyzable nucleotides to strong cystic fibrosis transmembrane conductance regulator (CFTR) agonists by gain of function (GOF) mutations.

Authors:  George Okeyo; Wei Wang; Shipeng Wei; Kevin L Kirk
Journal:  J Biol Chem       Date:  2013-04-25       Impact factor: 5.157

9.  Requirements for efficient correction of ΔF508 CFTR revealed by analyses of evolved sequences.

Authors:  Juan L Mendoza; André Schmidt; Qin Li; Emmanuel Nuvaga; Tyler Barrett; Robert J Bridges; Andrew P Feranchak; Chad A Brautigam; Philip J Thomas
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

Review 10.  The gating of the CFTR channel.

Authors:  Oscar Moran
Journal:  Cell Mol Life Sci       Date:  2016-10-01       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.